Coffee consumption and risk of stroke: A dose-response meta-analysis of prospective studies

American Journal of Epidemiology

Volumn 174, Issue 9, 2011, Pages 993-1001

  Larsson, Susanna C ^a   Orsini, Nicola ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

coffee; meta analysis; prospective studies; review; stroke

Indexed keywords

COFFEE; DOSE-RESPONSE RELATIONSHIP; HETEROGENEITY; LITERATURE REVIEW; META-ANALYSIS; NONLINEARITY; NUMERICAL MODEL; QUANTITATIVE ANALYSIS; RISK FACTOR; STROKE;

COFFEE; DATA EXTRACTION; DIETARY INTAKE; DOSE RESPONSE; EMBASE; HUMAN; MEDICAL RECORD REVIEW; MEDLINE; META ANALYSIS; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REVIEW; RISK; STROKE;

COFFEE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; RISK; RISK FACTORS; STROKE;

EID: 80054965213     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr226     Document Type: Review

References (38)

1. Natella F, Nardini M, Belelli F, et al. Coffee drinking induces incorporation of phenolic acids into LDL and increases the resistance of LDL to ex vivo oxidation in humans. Am J Clin Nutr. 2007;86(3):604-609. (Pubitemid 47435826)
2. Nardini M, D'Aquino M, Tomassi G, et al. Inhibition of human low-density lipoprotein oxidation by caffeic acid and other hydroxycinnamic acid derivatives. Free Radic Biol Med. 1995; 19(5):541-552.
3. Gómez-Ruiz JA, Leake DS, Ames JM. In vitro antioxidant activity of coffee compounds and their metabolites. J Agric Food Chem. 2007;55(17):6962- 6969. (Pubitemid 47338933)
4. Noordzij M, Uiterwaal CS, Arends LR, et al. Blood pressure response to chronic intake of coffee and caffeine: a metaanalysis of randomized controlled trials. J Hypertens. 2005; 23(5):921-928. (Pubitemid 40637906)
5. O'Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376(9735):112-123.
6. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-952. (Pubitemid 39208455)
7. Cornelis MC, El-Sohemy A. Coffee, caffeine, and coronary heart disease. Curr Opin Lipidol. 2007;18(1):13-19. (Pubitemid 46090231)
8. Wu JN, Ho SC, Zhou C, et al. Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies. Int J Cardiol. 2009;137(3):216-225.
9. Huxley R, Lee CM, Barzi F, et al. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med. 2009;169(22):2053-2063.
10. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008- 2012. (Pubitemid 30214957)
11. Harrell FE Jr, Lee KL, Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst. 1988;80(15):1198-1202.
12. Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stat J. 2006;6(1):40-57. (Pubitemid 43708443)
13. Jackson D, White IR, Thompson SG. Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. Stat Med. 2010;29(12):1282-1297.
14. Orsini N, Greenland S. A procedure to tabulate and plot results after flexible modeling of a quantitative covariate. Stat J. 2011; 11(1):1-29.
15. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558. (Pubitemid 34746062)
16. Egger M, Davey Smith G, Schneider M, et al. Bias in metaanalysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-634. (Pubitemid 27387172)
17. Heyden S, Tyroler HA, Heiss G, et al. Coffee consumption and mortality. Total mortality, stroke mortality, and coronary heart disease mortality. Arch Intern Med. 1978;138(10): 1472-1475. (Pubitemid 10232233)
18. Grobbee DE, Rimm EB, Giovannucci E, et al. Coffee, caffeine, and cardiovascular disease in men. N Engl J Med. 1990;323(15): 1026-1032. (Pubitemid 20336961)
19. Hakim AA, Ross GW, Curb JD, et al. Coffee consumption in hypertensive men in older middle-age and the risk of stroke: the Honolulu Heart Program. J Clin Epidemiol. 1998;51(6): 487-494. (Pubitemid 28310236)
20. Bidel S, Hu G, Qiao Q, et al. Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes. Diabetologia. 2006;49(11):2618-2626. (Pubitemid 44559523)
21. Silletta MG, Marfisi R, Levantesi G, et al. Coffee consumption and risk of cardiovascular events after acute myocardial infarction: results from the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico)-Prevenzione trial. Circulation. 2007;116(25):2944-2951. (Pubitemid 350291201)
22. Larsson SC, Männistö S, Virtanen MJ, et al. Coffee and tea consumption and risk of stroke subtypes in male smokers. Stroke. 2008;39(6):1681-1687.
23. Zhang WL, Lopez-Garcia E, Li TY, et al. Coffee consumption and risk of cardiovascular events and all-cause mortality among women with type 2 diabetes. Diabetologia. 2009;52(5): 810-817.
24. Lopez-Garcia E, Rodriguez-Artalejo F, Rexrode KM, et al. Coffee consumption and risk of stroke in women. Circulation. 2009;119(8):1116-1123.
25. Mukamal KJ, Hallqvist J, Hammar N, et al. Coffee consumption and mortality after acute myocardial infarction: the Stockholm Heart Epidemiology Program. Am Heart J. 2009; 157(3):495-501.
26. Sugiyama K, Kuriyama S, Akhter M, et al. Coffee consumption and mortality due to all causes, cardiovascular disease, and cancer in Japanese women. J Nutr. 2010;140(5): 1007-1013.
27. Leurs LJ, Schouten LJ, Goldbohm RA, et al. Total fluid and specific beverage intake and mortality due to IHD and stroke in the Netherlands Cohort Study. Br J Nutr. 2010;104(8): 1212-1221.
28. de Koning Gans JM, Uiterwaal CS, van der Schouw YT, et al. Tea and coffee consumption and cardiovascular morbidity and mortality. Arterioscler Thromb Vasc Biol. 2010;30(8): 1665-1671.
29. Mineharu Y, Koizumi A, Wada Y, et al. Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J Epidemiol Community Health. 2011;65(3):230-240.
30. Larsson SC, Virtamo J, Wolk A. Coffee consumption and risk of stroke in women. Stroke. 2011;42(4):908-912.
31. Arnlöv J, Vessby B, Risérus U. Coffee consumption and insulin sensitivity. JAMA. 2004;291(10):1199-1201.
32. Lopez-Garcia E, van Dam RM, Qi L, et al. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr. 2006;84(4): 888-893. (Pubitemid 44715672)
33. Kempf K, Herder C, Erlund I, et al. Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr. 2010;91(4): 950-957.
34. Kotani K, Tsuzaki K, Sano Y, et al. The relationship between usual coffee consumption and serum C-reactive protein level in a Japanese female population. Clin Chem Lab Med. 2008; 46(10):1434-1437.
35. Maki T, Pham NM, Yoshida D, et al. The relationship of coffee and green tea consumption with high-sensitivity C-reactive protein in Japanese men and women. Clin Chem Lab Med. 2010;48(6):849-854.
36. Winkelmayer WC, Stampfer MJ, Willett WC, et al. Habitual caffeine intake and the risk of hypertension in women. JAMA. 2005;294(18):2330-2335. (Pubitemid 41607409)
37. Jee SH, He J, Appel LJ, et al. Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol. 2001;153(4):353-362. (Pubitemid 32144561)
38. Derby KS, Cuthrell K, Caberto C, et al. Nicotine metabolism in three ethnic/racial groups with different risks of lung cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(12): 3526-3535.